Improved Heart Transplant Survival in Patients Bridged with Ventricular Assist Device
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2002-03-31
著者
-
Kato Tomoko
Division of Cardiology, National Cardiovascular Center
-
Hunt Sharon
Division Of Cardiovascular Medicine Stanford University Medical Center
-
Hunt Sharon
Division Of Cardiology Stanford University Hospital
-
Kato Tomoko
Division Of Cardiology Cardiovascular Center
-
Kato Tomoko
Division Of Cardiology Stanford University Hospital
-
Robbins Robert
Department Of Cardiovascular Surgery Stanford University
-
Chan Michael
Division of Cardiology, Stanford University Hospital
-
Hsao Esther
Division of Cardiology, Stanford University Hospital
-
Cantin Bernard
Division of Cardiology, Stanford University Hospital
-
Oyer Phillip
Department of Cardiovascular Surgery, Stanford University
-
Hsao Esther
Division Of Cardiology Stanford University Hospital
-
Oyer Phillip
Department Of Cardiovascular Surgery Stanford University
-
Chan Michael
Division Of Cardiology Stanford University Hospital
-
Cantin Bernard
Division Of Cardiology Stanford University Hospital
関連論文
- PE-342 Novel Point-of-Care Test for Oxidative Stress, ROM Test, Reflects Elevated Oxidation Levels in the Patients with Chronic Heart Failure(Heart failure, clinical-09, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-155 Reduced Left Ventricular Torsion with Two-Dimensional Speckle Tracking Echocardiography would Predict Acute Rejection in Heart Transplant Recipients.(Transplantation/LVAD (IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Ja
- Insulin Resistance and Fasting Hyperinsulinemia Are Risk Factors for New Cardiovascular Events in Patients With Prior Coronary Artery Disease and Normal Glucose Tolerance
- Improved Heart Transplant Survival in Patients Bridged with Ventricular Assist Device
- Factors Associated with Long-Term (>10 Years) Survival after Heart Transplantation in the Cyclosporine Era : Stanford Experience
- Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan
- Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan